None listed
Conditions
Interventions
Intervention1: Combined IPL and Forma Eye: Combination of Intense Pulse Light Therapy and Radio frequency
Intervention2: Forma Eye: Forma Eye (or Forma-I) is a non-invasive radiofrequency (RF) therapy
Sponsors
ProSight Eye Hospital
Eligibility
Inclusion criteria
Inclusion criteria: diagnosed MGD-related DED (based on TFOS DEWS II criteria: OSDI score, NIBUT, and evidence of gland dysfunction on meibography) Fitzpatrick skin types I-IV (for IPL safety, Groups A and C).
Exclusion criteria
Exclusion criteria: Active ocular infection, inflammation (e.g., severe blepharitis not related to MGD), or ocular surgery within 3 months. History of ocular herpes simplex or zoster. Use of topical antiglaucoma medications Use of systemic medications affecting tear production (e.g., isotretinoin, antihistamines) unless stable for more than 3 months. Pregnancy, lactation, or planning pregnancy. Photosensitivity disorders, epilepsy, or use of photosensitizing drugs (for IPL, Groups A and C). Pacemakers, metal implants near the eye, or coagulopathies (for RF, Groups B and C). Severe systemic diseases (e.g., uncontrolled diabetes, autoimmune disorders affecting the eyes).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Visual Acuity (Uncorrected and Best Corrected) - Non-Invasive Break-Up Time (NIBUT) Timepoint: - Baseline and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| -Meibography to evaluate meibomian gland morphology & atrophy -Ocular Surface Disease Index (OSDI) Scoring: Patient-reported symptom severity (0-100 scale). Validated 12-item questionnaire; higher scores indicate worse symptoms. -Schirmers 1 test -Schirmers 2 test Timepoint: Baseline & 3 months | — |
Countries
India
Contacts
Public ContactDr Sheetal Brar
ProSight Eye Hospital
Outcome results
None listed